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Lymphatic valves are essential for efficient
lymphatic transport, but the mechanisms of early
lymphatic-valve morphogenesis and the role of
biomechanical forces are not well understood. We
found that the transcription factors PROX1 and
FOXC2, highly expressed from the onset of valve
formation, mediate segregation of lymphatic-valve-
forming cells and cell mechanosensory responses
to shear stress in vitro. Mechanistically, PROX1,
FOXC2, and flow coordinately control expression
of the gap junction protein connexin37 and activa-
tion of calcineurin/NFAT signaling. Connexin37 and
calcineurin are required for the assembly and delim-
itation of lymphatic valve territory during develop-
ment and for its postnatal maintenance. We pro-
pose a model in which regionally increased levels/
activation states of transcription factors cooperate
with mechanotransduction to induce a discrete cell-
signaling pattern and morphogenetic event, such as
formation of lymphatic valves. Our results also
providemolecular insights into the role of endothelial
cell identity in the regulation of vascular mechano-
transduction.
INTRODUCTION
Lymphatic vasculature contains two distinct functional com-
partments: lymphatic capillaries, important for the uptake of
interstitial fluid, and collecting lymphatic vessels, which trans-
port lymph toward lymph nodes. Intraluminal lymphatic valves430 Developmental Cell 22, 430–445, February 14, 2012 ª2012 Elsevare the hallmark of the collecting-lymphatic-vessel phenotype.
They are composed of two semilunar leaflets, covered on both
sides by a specialized endothelium tightly anchored to an
extracellular matrix (ECM) core. Lymphatic valves prevent
lymph backflow: high hydrostatic pressure in the upstream
duct opens the valve and enables forward flow. In contrast, pres-
sure from the opposite direction pushes the two valve leaflets
together and thereby stops reverse lymph flow. Lymphatic-valve
dysfunction underlies some forms of human hereditary lymphe-
dema, and it is one of the likely causes of secondary lymphe-
dema, which affects up to 30% of breast cancer patients
following the resection of axillary lymph nodes (Rockson, 2008).
Few regulators of lymphatic-valve formation have been
identified to date. Loss of transcription factor Foxc2 and EphB
tyrosine kinase ligand ephrinB2 prevents formation of lymphatic
valves, whereas inactivation of integrin a9 or its ECM ligand
FN-EIIIA affects the elongation of lymphatic-valve leaflets,
leading to nonfunctional valves (Bazigou et al., 2009; Ma¨kinen
et al., 2005; Norrme´n et al., 2009; Petrova et al., 2004). FOXC2-
bound enhancers from lymphatic endothelial cells (LECs) are
enriched in binding sites for nuclear factor of activated T cells
(NFAT) transcription factors, and pharmacological inhibition of
calcineurin, an upstream regulator of NFAT activation, affects
lymphatic-valve formation (Norrme´n et al., 2009). Despite this
knowledge, the processes during early stages of lymphatic-valve
development are still not well understood. The transcription
factor Prox1, required for the establishment of lymphatic endo-
thelial cell identity (Wigle and Oliver, 1999), and Foxc2 are upre-
gulated, coexpressed, and required from the onset of lymphatic-
or lymphovenous-valve formation (Bazigou et al., 2009; Norrme´n
et al., 2009; Srinivasan and Oliver, 2011). Here, we investigated
how early lymphatic-valve morphogenesis is regulated via the
interplay of these transcription factors, mechanical stimulation
by lymph flow, and downstream target genes and pathways,
such as connexins and calcineurin signaling.ier Inc.
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Steps of Embryonic Lymphatic-Valve Formation
E15.5 mesenteric lymphatic endothelial cells form a network of
maturing collecting vessels (Norrme´n et al., 2009). Formation
of lymphatic valves is initiated around E16.0, and upregulation
of Prox1, followed by a less pronounced upregulation of Foxc2
shortly afterward, is the first sign of it (Figure 1A; Bazigou
et al., 2009; Norrme´n et al., 2009). Clusters of Prox1high
lymphatic-valve-forming cells (LVCs) further coalesce and form
a ring-like constriction composed of two to four rows of cells
(Figure 1A). The absolute number of cells in the ring varies with
the size of the lymphatic vessel (Figure S1A available online).
Formation of a ring-like constriction is followed by downregula-
tion of Foxc2 and Prox1 in cells that form the lymphangion
(part of lymphatic vessel between two valves). These cells
subsequently align and elongate in the direction of lymph flow.
Interestingly, Foxc2 and Prox1 are localized asymmetrically in
the regions immediately up- and downstream of LVCs: cells in
the upstream region express lower levels of Foxc2 (Prox1high/
Foxc2low), whereas cells located in the downstream region are
Prox1low/Foxc2high (Figure 1A). Polarized distribution of Prox1
and Foxc2 may indicate that the direction of future lymphatic
leaflet elongation is specified already at this stage.
During the next steps, a subset of LVCs is reoriented and
protrudes into the lumen, starts to elongate, and forms valve
leaflets (Figure 1B, top). These stages of lymphatic-valve forma-
tion are accompanied by deposition of ECM components, such
as laminin a5, collagen IV, and FN-EIIIA, and increased expres-
sion of integrin a9, which anchors LVCs to the leaflet ECMmatrix
(Bazigou et al., 2009; Norrme´n et al., 2009). Further deposition of
ECM components during valve maturation results in the thick-
ening of valve leaflets. In this study, we observed that LVC
clusters start to produce laminin a5 early during valve initiation
(Figure 1B, top).
Based on both previously published and new data, presented
here, we suggest a four-step model for the formation of lym-
phatic valves, with each step identified by a double staining for
Prox1 as an LVC marker and laminin a5 as an indicator of
lymphatic-valve maturation. Valve formation initiates as isolated
LVCs that first form a cluster of LVCs on one side of the collecting
vessel (Stage 1, initiation). Then LVC cluster gives rise to a ring-
like constriction (Stage 2, condensation). Next, increased depo-
sition of laminin a5, together with invagination of LVCs into the
lumen, indicates leaflet elongation (Stage 3, elongation). This is
followed by valve maturation when two leaflets can be observed
in association with a thick ECM core (Figure 1B, Stage 4,
maturation).
Morphological and Molecular Changes during Valve
Formation
We further characterized Prox1high LVCs by staining for Pecam1,
endothelial adherens junction protein VE-cadherin, F-actin, or
b-catenin that anchors actin cytoskeleton to cell-cell junctions.
Prox1high LVCs displayed a cuboidal shape, perinuclear F-actin
fibers, and b-catenin condensation (Figures 1C, S1B, and S1C).
Surrounding lymphangion endothelial cells displayedmore squa-
mous cell characteristics and cortical actin cytoskeleton and
b-catenin (Figures 1C, S1B, and S1C). Transition from squamousDevelopmto cuboidal cell shape has also been observed at early stages of
venous-valve development (Kampmeier and Brich, 1927) and in
zebrafish heart-valve endocardial cells (Beis et al., 2005), sug-
gesting that it is an important step in valve morphogenesis.
The lymphatic capillary marker LYVE-1 is downregulated in
postnatal collecting vessels (Ma¨kinen et al., 2005). We observed
that decrease in LYVE-1 is initiated already in early LVCs (Fig-
ure 1D). Receptors of lymphangiogenic factor Vegf-c, Vegfr-2,
and Vegfr-3 were expressed in both LVCs and lymphangion cells
(Figures 1E and 1F), but their coreceptor neuropilin-2 (Nrp2) was
selectively decreased in LVCs and mature valves (Figures 1G
and S1D).
Gap-Junction Protein Connexin37 and Calcineurin/
NFAT Signaling Are Induced in Early Lymphatic-Valve-
Forming Cells
The highly coordinated formation of ring-like constrictions by
LVCs suggested that cell-cell communication is involved in this
morphogenetic event. Therefore, we investigated the expression
of vascular connexin37 (Cx37), Cx43, and Cx40, which form gap
junctions and thusmay control collective cell behavior (Wei et al.,
2004). Cx37 was present in lymphatic vessels, as reported previ-
ously (Kanady et al., 2011). Importantly, we found that it is upre-
gulated in LVCs to a level comparable to that in nearby arteries
(Figure 1H). High Cx37 levels are observed shortly after Prox1
induction in a subset of LVCs. In contrast, Cx43 is highly ex-
pressed in embryonic lymphatic vessels, but is low in the early-
stage LVCs in comparison to lymphangion endothelial cells
(Figure 1I). Both Cx37 and Cx43 are expressed in the valves at
later stages of lymphatic-valve development, while Cx40 is low
in developing collecting lymphatic vessels (Figures S1E and
S1F; F. le Noble, personal communication; Kanady et al., 2011).
The Ca2+-dependent serine/threonine phosphatase calci-
neurin regulates nuclear translocation of NFAT transcription
factors (Wu et al., 2007). It has been suggested that calci-
neurin-dependent activation of Nfatc1 plays a role in both lym-
phangiogenesis and formation of collecting lymphatic vessels
in cooperation with Foxc2 (Kulkarni et al., 2009; Norrme´n et al.,
2009).We expanded this analysis by studying Nfatc1 localization
in developing lymphatic valves. Nuclear Nfatc1 accumulated in
LVCs, indicating activation of calcineurin signaling during early
stages of lymphatic-valve formation (Figure 1J).
To summarize, LVCs acquire a distinct identity, and they
undergo both morphological (cuboidal cell shape acquisition
and cytoskeleton reorganization) and molecular transition (Fig-
ure 1K), raising questions about mechanisms and roles of these
changes in lymphatic-valve formation.
Cx37 Is Essential for Assembly of the Ring-like Valve
Territory In Vivo
We next studied the functional significance of increased Cx37
expression in LVCs. As reported previously (Kanady et al.,
2011; Simon and McWhorter, 2002), blood vascular develop-
ment and lymphatic endothelial differentiation were normal in
Cx37/ mice (Figures S2A and S2B), but most lymphatic
vessels lacked lymphatic valves, resulting in a severely per-
turbed lymphatic drainage in adults (Figure S2C). We sought to
investigate next the mechanisms underlying loss of valves in
Cx37/ mice. Prox1high/Foxc2high LVC clusters were detectedental Cell 22, 430–445, February 14, 2012 ª2012 Elsevier Inc. 431
Figure 1. Characterization of Lymphatic Valve-Forming Cells
(A) Prox1 and Foxc2 expression at early stages of lymphatic valvemorphogenesis. Top (Stage 1): Prox1 is upregulated during lymphatic valve initiation in a subset
of LECs (arrowheads). A, artery. Bar, 100 mm. Bottom (Stage 2): ring-like constriction is formed by Prox1high/Foxc2high cells. Prox1high ring is upstream of the valve
(red arrowhead); Foxc2high ring is downstream of the valve (green arrowhead). Bar, 50 mm. E16.0 and E17.0 mesenteric lymphatic vessels were stained for Prox1
(red) and Foxc2 (green).
(B) Stages of lymphatic-valve morphogenesis, showing staining of mesenteric lymphatic vessels for Prox1 (red) and laminin a5 (green) (Ringelmann et al., 1999).
Bar, 20 mm.
(C) Valve-forming cells have a cuboidal shape. E16.5mesenteric lymphatic vessels were stained for Prox1 (blue), Pecam1 (green), and VE-cadherin (red). Bottom:
transverse sections of the vessel at the valve site (position 1) and in the lymphangion (position 2) obtained by x-z reconstructions from the confocal 3D picture.
Arrowheads indicate shapes of nuclei in cuboidal and squamous lymphatic endothelial cells. Bar, 20 mm.
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Figure 2. Cx37 Controls the Assembly of Circumferential Valve Territory
(A) Cx37 regulates lymphatic valve formation. E18.5 mesenteric vessels were stained for Prox1 (red) and laminin a5 (green). Arrowheads indicate mature valve
sites, and arrows indicate immature valve sites. A, artery. Bar, 100 mm.
(B) Defective circumferential assembly of a valve site in Cx37/ mice. E18.5 mesenteric vessels were stained for Vegfr-3 (green) and Prox1 (red). Bar, 80 mm.
(C) Quantification of mesenteric lymphatic valves in E18.5 embryos. *p < 0.05, **p < 0.005, ***p < 0.001, n = 10 embryos per genotype.
(D) The number of lymphatic valves is reduced in adult Cx37/ mice. Diaphragms were stained for VE-cadherin (blue), Foxc2 (green), and laminin a5 (pink).
Arrowheads indicate lymphatic valves. Bar, 70 mm.
(E) Cx37 expression is reduced in Foxc2/mice. E17.5 mesenteric vessels were stained for Prox1 (red) and Cx37 (green). Arrowheads indicate lymphatic valves.
A, artery. Bar, 20 mm.
(F) Partial genetic interaction of Foxc2 and Cx37. The number of valves at the initial assembly, stages 1 and 2, is increased in E18.5 Foxc2+/; Cx37+/ mice.
*p < 0.005 versus Cx37+/, $p < 0.01 versus Foxc2+/, n = 3 embryos per genotype. Stages of valve development are as in Figure 1B.
See also Figure S2. All values are means ± SD.
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However, LVCs failed to reorganize and form the ring-like
constrictions observed in the control littermates (Figure 2B).
The total number of valves was decreased and the majority
was arrested at the initial stages of development (Figure 2C).
Valve formation was arrested and not simply delayed, as
lymphatic valves were almost absent in all adult Cx37/ tissues
tested (Figures 2D and S2E). Unlike the case for prenatal(D–G) LYVE-1 and Nrp2, but not Vegfr-2 and Vegfr-3, are decreased in lymphatic-
Vegfr-2, Vegfr-3, and Nrp2 (blue), and Prox1 (red). Bar, 20 mm.
(H) Cx37 is upregulated in lymphatic-valve-forming cells. E17.0mesenteric lympha
(I) Cx43 is downregulated in lymphatic-valve-forming cells. E17.0 mesenteric ly
indicate the lymphatic valve site. Bar, 20 mm.
(J) Calcineurin/NFAT pathway is activated in lymphatic-valve-forming cells. E17.
valve at stage 1 (initiation); right, valve at stage 3 (elongation). L, lumen. Arrowhe
(K) Molecular characteristics of early lymphatic-valve-forming cells.
See also Figure S1.
Developmlymphatic vessels, no isolated LVC clusters were observed in
the adults, although a few fully mature valves were found (data
not shown). These results suggest that LVC clusters are unstable
in the absence of Cx37 and revert to the surrounding lymphan-
gion phenotype. However, when a sufficient number of cells is
present, further valve development appears to proceed normally.
Foxc2/ embryos fail to develop lymphatic valves (Petrova
et al., 2004), and Cx37 protein was almost completely absentvalve-forming cells. E16.5 mesenteric vessels were stained for LYVE-1 (green),
tic vessels were stained for Prox1 (red) and Cx37 (green). A, artery. Bar, 30 mm.
mphatic vessels were stained for Prox1 (red) and Cx43 (green). Arrowheads
5 sections were stained for DNA (blue), Prox1 (pink), and Nfatc1 (green). Left:
ads indicate the lymphatic-valve-forming cell. Bar, 10 mm.
ental Cell 22, 430–445, February 14, 2012 ª2012 Elsevier Inc. 433
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unaltered in arteries, which also express Foxc2 (Figure 2E).
Comparison of LECs isolated from Foxc2/ with those
from control wild-type mice demonstrated a significant reduc-
tion in Cx37 mRNA (Figure S2F). These results, which are in
agreement with Kanady et al. (2011), suggested that Cx37 is
one of the downstream effectors of Foxc2 in the regulation of
collecting-lymphatic-vessel phenotype and lymphatic-valve
formation. To further validate this hypothesis, we analyzed
lymphatic valves in double heterozygous Foxc2+/; Cx37+/
mice. We found that heterozygous loss of both Foxc2 and
Cx37 reduced the proportion of mature valves (Figure 2F).
However, unlike in Cx37/ mice, the total number of valves
was not affected, suggesting that additional mechanisms are
involved.
Collectively, these data show that Cx37 regulates the transi-
tion from the early LVC cluster to a circumferential lymphatic
valve territory. Loss of Cx37 prevents the formation of lymphatic
valves and leads to a profoundly abnormal lymphatic drainage
(Figures S2C and S2G).
Cell-Autonomous Calcineurin Signaling Controls
Demarcation of the Lymphatic-Valve Territory
Pharmacological inhibition of calcineurin decreases lymphatic
sprouting and maturation of collecting lymphatic vessels (Kul-
karni et al., 2009; Norrme´n et al., 2009). However, calcineurin
is ubiquitously expressed, and it is not known whether the
observed lymphatic vascular defects are cell-autonomous. To
answer this question, we inactivated calcineurin regulatory
subunit Cnb1 in different endothelial compartments after E12.5
(Figure S3A). Loss of Cnb1 in blood endothelial cells (Figures
S3B and S3C) did not affect patterning of blood or lymphatic
vessels (Figures S3D–S3F), demonstrating that calcineurin is
dispensable for late embryonic angiogenesis. Pan-endothelial
Cnb1 inactivation affected neither overall development, heart-
valve formation, blood patterning, or lymphatic capillary
patterning (Figures S3G–S3K). In contrast, loss of Cnb1 resulted
in poor demarcation of valve territory in developing collecting
lymphatic vessels; i.e., a sharp boundary between Prox1low
and Prox1high cells, observed in the control mice, was replaced
by a large ring of Prox1high cells, which failed to polarize and
invaginate into the lumen (Figures 3A and 3B). A similar pheno-
type was observed when Cnb1 was inactivated in lymphatic
endothelial cells (Figures S3L and S3M). These data demon-
strate that calcineurin signaling is required cell-autonomously
for lymphatic-valve formation. In contrast, defects of lymphatic
capillary sprouting observed after cyclosporin A treatment or in
calcineurin Ab-deficient mice (Kulkarni et al., 2009; Norrme´n
et al., 2009) may be due to the suppression of this pathway in
nonendothelial cell type(s).
Calcineurin Signaling Is Necessary for the Maintenance
of Lymphatic Valves
The calcineurin pathway remains active in adult lymphatic valves
in both humans and mice (Figure 3C; data not shown). To study
its role in valve maintenance, we inactivated Cnb1 in the
lymphatic vasculature of newborn pups and studied vessel
morphology at postnatal day 7. Lymphatic valves of the control
mice had elongated leaflets with well-formed laminin a5 ECM434 Developmental Cell 22, 430–445, February 14, 2012 ª2012 Elsevcore (Figure 3D). In contrast, the number of valves and the
ECM deposition were significantly reduced upon inactivation of
Cnb1 (Figures 3D and 3E), suggesting that postnatal loss of
calcineurin signaling leads to valve-leaflet regression or degen-
eration. Furthermore, inactivation of calcineurin in fully mature
lymphatic valves in adult mice resulted in significant shortening
of the ECM core (Figures 3F and 3G). These results reveal
a need for continuous calcineurin activation during the establish-
ment and maintenance of lymphatic valves.
FOXC2 and PROX1 Control Cx37 Expression and
Calcineurin/NFAT Activation in Response to Flow
We next asked what mechanisms underlie enhanced expression
of Cx37 and activation of calcineurin/NFAT in LVCs. Lymphan-
giogenic growth factor VEGF-C activates calcineurin/NFAT sig-
naling in lymphatic endothelial cells (LECs) through VEGFR-2
(Norrme´n et al., 2009). However, VEGF-C-elicited activation of
calcineurin/NFAT was transient (Figures 4A and S4A), and
VEGF-C decreased both FOXC2 and Cx37 proteins (Figures
4B and S4B). In addition, VEGF-C induced cell elongation (Fig-
ure 4C), whereas LVCs in vivo have a cuboidal shape (Figures
1C and S1B). These results suggest that VEGF-C is an unlikely
candidate for the coordinate induction of Cx37 and calcineurin/
NFAT activation in LVCs in vivo.
Reversing blood flow triggers heart-valve formation in zebra-
fish (Vermot et al., 2009) and lymphatic valves frequently form
at vessel bifurcations (Kampmeier, 1928; Figure S1G), corre-
sponding to areas of disturbed flow (Hahn and Schwartz,
2009). We next tested whether calcineurin/NFAT and Cx37 are
induced in LECs by reversing flow, which we modeled by oscil-
latory fluid shear stress (OSS), based on the values reported for
collecting lymphatic vessels (Zawieja, 2009). OSS induced a
strong sustained accumulation of nuclear NFATc1 and expres-
sion of Cx37, whichwere abrogated byPROX1 or FOXC2 knock-
down (Figures 4D–4F and S4C–S4G). In contrast, Cx43, which
has been suggested to act together with Cx37 in lymphatic
vasculature (Kanady et al., 2011), was repressed by OSS, similar
to early LVCs in vivo (Figures 4G and S4G). The expression of
Cx43 under static conditions was dependent on PROX1,
whereas depletion of FOXC2 had little effect on Cx43 mRNA
(Figures S4C and S4G). Thus, it is possible that Cx43 cooperates
with Cx37 at late stages of valve formation or that perhaps Cx43
is involved in nonendothelial cells. Most importantly, these
results show that, unlike VEGF-C, flow coordinately induces
Cx37 and calcineurin/NFAT activation in a PROX1- and
FOXC2-dependent manner.
Cx37 Acts Upstream of Calcineurin/NFAT Activation
in Lymphatic Endothelial Cells
Connexin45 acts upstream of calcineurin during heart-valve
formation (Kumai et al., 2000). We asked whether Cx37 contrib-
utes to the activation of calcineurin/NFAT in response to flow.
Cx37 depletion significantly decreased calcineurin/NFAT activa-
tion byOSS (Figures 4H and S4F). While there was a uniform loss
of nuclear NFATc1 upon depletion of FOXC2 or PROX1 (Fig-
ures 4D and 4E), loss of Cx37 resulted in a distinct pheno-
type, i.e., there were many isolated cells with high nuclear
NFATc1. These results suggest that Cx37 acts downstream of
PROX1 and FOXC2 to create a coordinated field of activatedier Inc.
Figure 3. Cell-Autonomous Calcineurin Signaling Controls Lymphatic-Valve Morphogenesis and Maintenance
(A) Lymphatic valve formation is impaired in Cnb1ecKO mice. E18.5 mesenteric vessels were stained for Prox1 (red) and Pecam1 (green). ecKO, endothelial cell
knock-out; ecWT, wild-type. Arrowheads indicate mature lymphatic valves; arrows point to failure of valve condensation in Cnb1ecKO mice. Bar, 100 mm.
(B) Quantification of lymphatic valves and their maturation stage at E18.5. Stages of valve development are as in Figure 1B. *p < 0.05, **p < 0.001, n = 10 embryos
per genotype. ecKO, endothelial cell knock-out; ecWT, wild-type.
(C) Activated NFATc1 in adult human lymphatic valve. Cells were stained for PROX1 (pink), NFATc1 (green), and DNA (blue). Arrowheads indicate the lymphatic
valve leaflet. L, lumen. Bar, 10 mm.
(D) Postnatal loss of Cnb1 leads to valve degeneration. P7 mesenteric vessels from Cnb1lecKO or the control mice stained for Pecam1 (green), Prox1 (blue), and
laminin a5 (red). The double arrow indicates the valve laminin a5 ECM core. lecKO, lymphatic endothelial cell knock-out; lecWT, wild-type. Bar, 20 mm.
(E) Quantification of valve number (blue bars) and ECM core length (red bars) in mesenteric vessels of P7 Cnb1lecKO or the control mice. *p < 0.05, n = 6 pups per
genotype. lecKO, lymphatic endothelial cell knock-out; lecWT, wild-type.
(F) Adult lymphatic valves require continuous calcineurin signaling. Ear lymphatic vessels of the control Cnb1lecWT,Cnb1lecKO and Cnb1f/f;ROSA26R-YFP;Prox1-
CreERT2 mice were stained for YFP (green) and laminin a5 (red). YFP indicates sites of Cre-recombination. Note the normal development of YFP-negative
lymphatic valve and shortened laminin a5 ECM core in YFP-expressing valves. The double arrow indicates the laminin a5 ECM core of the valve leaflet. A,
arteriole. lecKO, lymphatic endothelial cell knock-out; lecWT, wild-type. Bar, 20 mm.
(G) Quantification of laminin a5 ECM core length in adult Cnb1lecKO or control mice. *p < 0.05, n = 10 valves per mouse. lecKO, lymphatic endothelial cell knock-
out; lecWT, wild-type.
See also Figure S3. All values are means ± SD.
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Figure 4. PROX1, FOXC2, and Shear Stress, but not VEGF-C, Coordinately Control Expression of Cx37 and Sustained Activation of
Calcineurin/NFATc1 in Lymphatic Endothelial Cells
(A) Transient activation of calcineurin/NFATc1 in LECs in response to VEGF-C and quantification of nuclear NFATc1 in LECs treatedwith VEGF-C (red line) or BSA
(blue line).
(B) VEGF-C suppresses FOXC2 and Cx37 expression at 24 hr. Western blot for the indicated proteins.
(C) VEGF-C induces elongation of LECs. b-catenin (pink) and DNA (blue) in LECs treated with VEGF-C or BSA for 24 hr.
(D) PROX1- and FOXC2-dependent NFATc1 activation by oscillatory shear stress. LECs transfected with AllStars control, PROX1, or FOXC2 siRNAs, were
subjected to OSS or left under static conditions for 48 hr. NFATc1 (green), DNA (gray). The threshold of NFATc1 detection was set up to detect only nuclear
NFATc1. Bar, 50 mm.
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Cx37 and calcineurin in endothelial cells synergistically impaired
the development of lymphatic valves. The resulting phenotype
was reminiscent of homozygous loss of Cnb1, in which LVCs
fail to condense (Figures 4I and 4J). Taken together, these data
suggest that Cx37 acts upstream of calcineurin/NFAT and lend
support to a model in which Cx37 and calcineurin belong to a
mechanotransduction cascade downstream of PROX1 and
FOXC2.
Oscillatory Fluid Shear Stress Induces Lymphatic
Valve-Forming Cell Characteristics in Cultured
Lymphatic Endothelial Cells
To study whether flow regulates other LVC characteristics, we
analyzed cell shape and actin cytoskeleton organization in
LECssubjected toOSSor laminar shear stress (LSS), asacontrol.
As described previously, under static conditions, LECs had vari-
able shape and size and cortical actin cytoskeleton (Petrova
et al., 2002; Figure 5A). OSS induced a cuboidal cell shape
(length/width ratio close to 1) and increased the amount of short
perinuclear F-actin stress fibers (Figures 5Aand5B), a phenotype
similar to theoneobserved in LVCs in vivo (FigureS1C). Exposure
to LSS resulted in moderate LEC elongation and formation of
stress fibers, aligned in the flow direction (Figures 5A–5C).
Thus, LECs under static, OSS, and LSSconditions are character-
ized by distinct cytoskeletal organization andmorphology. Expo-
sure toOSS results in the formation of cuboidal cells, reminiscent
of LVCs in vivo, whereas cells under LSS elongate and align in
flow, reproducing lymphangion cell morphology.
We next investigated how OSS and LSS affect the expression
of blood endothelial shear-stress-responsive genes KLF2 and
eNOS (Boon and Horrevoets, 2009). As reported previously for
blood endothelial cells, only LSS induced KLF2 mRNA (Fig-
ure 5D). Both OSS and LSS induced eNOS mRNA and protein
in comparison to static conditions (Figures 5D and 5E), suggest-
ing that eNOS is an indicator of flow onset in lymphatic vessels
in vivo. We also studied whether the two types of flow regulate
the expression of LYVE-1 andNRP2, which are selectively down-
regulated in LVCs in vivo (Figures 1D and 1G). OSS and, to
a lesser extent, LSS downregulated LYVE-1, while OSS specifi-
cally decreased NRP2 mRNA and protein (Figures 5F and 5G).
We next studiedwhether flow affects the expression of PROX1
and FOXC2. OSS, but not LSS, upregulated FOXC2, whereas
PROX1 was not affected (Figure 5H). While induction of Cx37
required both PROX1 and OSS (Figure 4F), the expression of
PROX1 target gene VEGFR-3 was not significantly modified
under these conditions (Yoshimatsu et al., 2011; Figure 5I).
Thus, PROX1 appears to have both constitutive and shear-
stress-inducible transcriptional activities. Collectively, these
results suggest that in vitro OSS reproduces many, albeit not(E) Quantification of nuclear NFATc1. *p < 0.001 versus control siRNA; **p < 0.00
(F) PROX1- and FOXC2-dependent induction of Cx37 by oscillatory shear stress
(G) Oscillatory shear stress decreases Cx43, as shown by staining for Cx43 (cya
(H) Cx37 depletion prevents uniform calcineurin/NFATc1 activation in response t
(I) Genetic interaction betweenCx37 and calcineurin signaling in E18.5mesenteric
valve sites at stages 3 and 4, and the arrow indicates the valve site at stage 1. A
(J) Number of mesenteric lymphatic valves at different stages in E18.5 Cnb1ecHET
embryos. Stages of valve development are as in Figure 1B.
See also Figure S4. All values are means ± SD.
Developmall, features of LVCs, such as downregulation of LYVE-1, NRP2,
and Cx43, a switch to cuboidal cell shape, enhanced expression
of FOXC2 and Cx37, and activation of calcineurin/NFAT.
PROX1 and FOXC2 Control LEC Cytoskeletal
Reorganization and Cell Alignment in Response to Flow
We investigated next whether PROX1 and FOXC2 control cyto-
skeletal responses of LECs to shear stress. PROX1-depleted
cells had highly variable shape and size, and they were unable
to adopt the cuboidal shape under OSS (Figures 6A and 6B).
PROX1 knockdown promoted formation of long stress fibers,
normally observed only in cells under LSS (Figure S5A). Even
under static conditions, PROX1-depleted cells aligned in the
long axis of the flow chamber (Figures 6A and 6C). Under LSS,
loss of PROX1 dramatically enhanced cell elongation and align-
ment in the direction of flow, leading to the formation of very long
and thin cells with a length/width ratio up to 35 (Figures 6A–6C).
PROX1 depletion also decreased VE-cadherin at cell-cell
contacts without affecting total VE-cadherin protein (Figures
6A, S4C, and S5B). In summary, these results show that loss
of PROX1 abolishes the LEC response to OSS while it enhances
cell elongation and alignment in response to LSS.
In contrast to PROX1 results, knockdown of FOXC2 did not
prevent cuboidal cell shape acquisition under OSS (Figures 6A
and 6B). The most striking feature of FOXC2 depletion was the
induction of circumferential thick actin fibers and star-like
bundles (Figure S5A). Loss of FOXC2 also resulted in disorgani-
zation of adherens junctions under OSS conditions, suggesting
impairment of junction integrity (Figure S5B). Cells under LSS
had enhanced cell elongation, although to a lesser degree com-
pared to PROX1 knockdown (Figures 6A–6C). Upon combined
inactivation of PROX1 and FOXC2, the behavior of cells under
OSS was similar to that of FOXC2 knockdown, whereas cells
under LSS adopted the ultraelongated phenotype similar to
PROX1 depletion (Figures 6A–6C). Altogether, these results indi-
cate that FOXC2 and PROX1 have similar effects on calcineurin
activation and Cx37 expression in response to shear stress, but
they play distinct roles in the organization of actin cytoskeleton
and cell-cell junctions in LECs subjected to flow.
Differential Levels of PROX1 and FOXC2 Induce Cell
Segregation
Isolated LVCs (Figures 1C and S1B) are rarely observed after the
onset of valve formation. Thus, we asked whether differential
levels of Prox1 and Foxc2 might be responsible for LVC clus-
tering and formation of lymphatic-valve territory. To test this
hypothesis, we mixed PROX1high/FOXC2high (as a model of
LVCs, transfected with control siRNA) and PROX1low/FOXC2low
LECs (as a model of lymphangion cells, transfected with
PROX1 and FOXC2 siRNAs) and evaluated cell segregation. To1 versus static conditions.
. Cells were stained for Cx37 (pink) and DNA (blue). Bar, 30 mm.
n) and DNA (blue). Bar, 30 mm.
o shear stress. Staining for NFATc1 (green) and ZO-1 (red). Bar, 100 mm.
vessels stained for Prox1 (red) and laminin a5 (green). The arrowheads indicate
, artery. Bar, 100 mm.
, Cx37+/ (n = 4 embryos per genotype) and double Cnb1ecHET; Cx37+/ (n = 2)
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Figure 5. In Vitro Oscillatory Shear Stress Reproduces Features of Lymphatic-Valve-Forming Cells
(A) Cell shape and actin cytoskeleton organization in LECs under static, oscillatory (OSS), or laminar (LSS) conditions. Top: cells are cuboidal in OSS and are
elongated and aligned in the direction of flow in LSS. Cells were stained for ZO-1 (yellow) and DNA (blue). Bar, 50 mm.Middle and bottom panels: cortical F-actin in
cells under static conditions, OSS induces short perinuclear stress fibers and LSS induces long stress fibers aligned in the flow direction. Cells were stained for
ZO-1 (red), F-actin (green), and DNA (blue). Arrowheads indicate actin stress fibers. Bottom: cell length (L) andwidth (W) were used for quantification of cell-shape
changes and alignment relative to flow. Bar, 20 mm.
(B) Quantification of cell shape in static, OSS, or LSS conditions. The cell is round when L/W = 1. *p < 0.001.
(C) Quantification of cell alignment under static, OSS, or LSS conditions. Cell is alignedwith the flowwhen the angle between its length and the flow direction is 0.
In the static condition, the long axis of the flow chamber was used for the measurements. *p < 0.001.
(D) Regulation of KLF2 and eNOS mRNA by shear stress. RT-qPCR was used for the indicated transcripts. *p < 0.01.
Developmental Cell
Flow, Prox1, and Foxc2 in Lymphatic Valve Formation
438 Developmental Cell 22, 430–445, February 14, 2012 ª2012 Elsevier Inc.
Developmental Cell
Flow, Prox1, and Foxc2 in Lymphatic Valve Formationdistinguish between cell populations, PROX1high/FOXC2high
LVC-like cells were labeled with a fluorescent membrane-
permeant dye (Figure S5C). As a control, we used a mix of
labeled and unlabeled LECs transfected with the control siRNA
(homogeneous population). When comparing these two condi-
tions,we found that the heterogeneouspopulation had a reduced
number of isolated single-labeled cells (15% versus 21% in the
homogeneous population) and an increased number of cells
assembled into large clusters (38% versus 21% in the homoge-
neous population) (Figures 6D and 6E), leading to the establish-
ment of valve-like territories in vitro. There was no difference
between static and OSS conditions (Figures 6D and 6E), indi-
cating that cell segregation depends on PROX1 and FOXC2,
but not mechanical stimulation. Importantly, only PROX1high/
FOXC2high LVC-like, and not PROX1low/FOXC2low cells, accu-
mulated nuclear NFATc1 under OSS (Figure 6D). Thus, differen-
tial levels of PROX1 and FOXC2 are sufficient to induce cell
segregation, whereas shear stress activates distinct signaling
in the two cell types, providing a mechanism for further amplifi-
cation of initial differences between the two adjacent cell
populations.
To test what cell-surface molecules mediate cell segrega-
tion, we studied the role of VE-cadherin, upregulated in LVCs
(Figure 1C), or Nrp2, downregulated in LVCs (Figure 1G).
VE-cadherinhigh LVC-like cells segregated from VE-cadherinlow
cells (64% labeled cells in large clusters versus 15% in a homo-
geneous population), whereas loss of NRP2 had no effect
(Figures 6F, 6G, S5F, and S5G). These results thus suggest
that the high levels of VE-cadherin observed in LVCs contribute
to the establishment of the valve territory.
In Vivo Analysis of Lymphatic Flow
Data on lymphatic flow duringmouse embryonic development are
scarce. LECsarise in embryonic veins fromE9.5 andbegin sprout-
ing around E10.5. However, Vegfc/ and Prox1/ embryos,
which lack lymphatic vessels, die by E15.5 (Karkkainen et al.,
2004; Wigle and Oliver, 1999), suggesting that lymph drainage
becomes critical from this point onward. eNOS was induced in
LECs in vitro by shear stress (Figure 5E), suggesting that eNOS
can be used as a marker of increased flow in vivo. eNOS was
low in immaturemesenteric lymphatic vessels at E15.0 (Figure 7A).
In contrast, increased levels of eNOS and podocalyxin, a sialomu-
cin of the endothelial glycocalyx necessary for shear-stress-
induced NO production (Tarbell and Ebong, 2008), were observed
at later stages in E15.5 collecting lymphatic vessels before the
appearance of Prox1high LVCs (Figures 7A and 7B), suggesting
that flow increase precedes lymphatic valve formation.
We next studied embryonic lymphatic flow using fluorescent
lymphangiography. Lymph flow was present in E16.0 embryos,
but it was reversing in many areas, especially at vessel bifurca-
tions, in line with the absence of formed lymphatic valves at
this stage (Figure 7C andMovie S1). In contrast, flow was mostly(E) Both LSS and OSS induce eNOS protein in comparison to static conditions.
(F) OSS decreases LYVE-1 and NRP2 mRNA. RT-qPCR was used for the indica
(G) OSS downregulates LYVE-1 and NRP2 proteins. Cells were stained for LYVE
(H) OSS increases FOXC2, as shown by western blot for the indicated proteins.
(I) VEGFR-3 is not significantly regulated by low shear stress, as shown by RT-qPC
All values are means ± SD.
Developmdirectional at E18.5, when lymphatic valves are formed (Fig-
ure 7D and Movie S1). To confirm the identity of the dye-filled
vessels, we injected Prox1-mOrange2 embryos in which lym-
phatic vessels are genetically marked by a fluorescent protein
(Figure S6). At E14.5 flow was almost absent despite the pres-
ence of lymphatic vessels (Figure S6C; data not shown), but
starting from E15.5, lymphatic-vessel filling and drainage were
observed (Figure 7E).
We next visualized adult lymphatic-valve dynamics (Figure 7F
and Movie S2) and the unidirectional pulsatile lymphatic flow
using a skinfold chamber model (Movie S3). In agreement with
the flow pattern reported in venous valves (Chiu and Chien,
2011), we observed nondirectional movement of autofluorescent
particulate material in the lymphatic-valve sinuses (Movie S3),
suggesting flow recirculation in this area. Based on in vitro and
in vivo data, we propose that flow recirculation in mature
lymphatic valve sinuses maintains high levels of Foxc2, Cx37,
activated calcineurin/NFATc1, and eNOS, while it represses
Nrp2 (Figure 7G).
Studies of mechanotransduction in developing blood vessels
rely on the possibility of modifying blood-flow velocity by altering
heart-pumping activity (Adamo et al., 2009; May et al., 2004;
Vermot et al., 2009). Lymphatic flow is not driven by a central
pump, but rather by the local compression of surrounding
tissues; thus, the methods developed to study developmental
hemodynamics cannot be applied. Therefore, we studied
lymphatic vessels cultured ex vivo, in which compression of
surrounding tissues is abrogated. Ex vivo culture led to disas-
sembly of lymphatic-valve territories and loss of patterned
expression of Prox1 and Foxc2 (Figure 7H). Although alternative
explanations are possible, these data suggest that the develop-
ment of lymphatic valves requires mechanical stimulation.
DISCUSSION
This study defines the molecular mechanisms of a fascinating
vascular morphogenetic event, the formation of lymphatic
valves. We show that lymphatic-valve-forming endothelial cells
are characterized by distinct morphological and molecular
properties (Figure 1K). Furthermore, we establish a hierarchy of
molecular events during early stages of lymphatic valve develop-
ment (Figure S7). Prox1 and Foxc2 act as upstream regulators of
Cx37 expression and calcineurin/NFAT activation, which in turn
contribute to different steps of lymphatic valve formation:
assembly of lymphatic-valve-forming cells into a ring-like struc-
ture, valve-territory delimitation, and postnatal valve mainte-
nance (Figure S7). Importantly, flow coordinately induces Cx37
expression and calcineurin activation in vitro, and this response
requires both Prox1 and Foxc2. We thus propose that the
cooperation between lymphatic endothelial transcription factors
Foxc2 and Prox1 and mechanical forces is essential for
lymphatic-valve morphogenesis (Figure S7).Cells were stained for eNOS (orange), VE-cadherin (red), and DNA (blue).
ted transcripts. *p < 0.01, **p < 0.001.
-1 or NRP2 (orange), VE-cadherin, or ZO-1 (red) and DNA (blue). Bar, 20 mm.
R. n.s., not significant; LSS, laminar shear stress; OSS, oscillatory shear stress.
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Figure 6. PROX1 and FOXC2 Control Mechanotransduction and Clustering of Lymphatic Endothelial Cells
(A) Effects of shear stress on LEC shape in the presence and in the absence of PROX1 and/or FOXC2. Cells were stained for VE-cadherin (red) and DNA (blue).
Bar, 50 mm.
(B) Quantification of cell-shape changes.
(C) Quantification of changes in cell alignment relative to flow direction.
(D) PROX1high/FOXC2high and PROX1low/FOXC2low cells segregate in two different populations. CellTracker labeled PROX1high/FOXC2high were mixed with
unlabeled PROX1low/FOXC2low or PROX1high/FOXC2high, as a control, and subjected to OSS or left under static conditions. Cells were stained for ZO-1 (red),
CellTracker (gray), andNFATc1 (green). For visualization, CellTracker-labeled cells are pseudocolored in gray. Figure S5C shows an example of the original image.
(E) Quantification of cell cluster formation. *p < 0.001.
(F and G) Differential levels of VE-cadherin but not NRP2 contribute to LEC segregation. *p < 0.001. LSS, laminar shear stress; OSS, oscillatory shear stress.
See also Figure S5.
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Regulators of Mechanotransduction
Flow plays an important role in the morphogenesis of blood
vessels. Here we report that PROX1 and FOXC2 regulate
multiple aspects of lymphatic endothelial cell response to fluid
shear stress in vitro, such as cytoskeletal rearrangement, cell
shape remodeling, and cell alignment. A close link between the
transcription factors PROX1 and FOXC2 and mechanosensory
signal transduction in LECs also demonstrates that endothelial
cell identity shapes cellular responses tomechanical stimulation.
This idea is also in line with differential responses of lymphatic
and blood vascular endothelial cells to interstitial flow (Ng
et al., 2004). Further analysis of PROX1- and FOXC2-dependent
mechanosensitive genes should provide detailed information on
the molecular mechanisms involved.
A number of lymphatic endothelial cell responses to shear
stress, such as Cx37 expression and calcineurin/NFAT activa-
tion, are regulated by both PROX1 and FOXC2, suggesting
cooperation between these two transcription factors. In line
with these observations, we observed a 15%–20% overlap in
gene-expression profiles of LECs following the knockdown of
PROX1 or FOXC2 under static conditions (unpublished data).
Direct comparison of gene-expression profiles and FOXC2/
PROX1 binding sites using ChIP/RNA-seq from LECs subjected
to flow should reveal whether this transcriptional overlap is due
to co-occupancy of common enhancers or interaction of
signaling pathways on a higher level.
In vitro comparison of oscillatory versus laminar flow revealed
that OSS induces many characteristics of lymphatic valve-form-
ingcells,while LSSconfers a lymphangion-likephenotype. Taken
together with the in vivo analysis of flow during development,
these results support amodel in which reversing flow contributes
to the formation of lymphatic valves (Figure S7). This model also
explains why lymphatic valves are frequently formed at vessel
bifurcations (Figure S1G), as these regions are more likely to
have flow recirculation (Chiu and Chien, 2011; Hahn and
Schwartz, 2009). Developing lymphatic vessels in vivo are sub-
jected to highly variable mechanical forces, e.g., pulsatile and
turbulent flow and mechanical stretching; therefore, future work
should include more precise quantitative analysis of embryonic
lymph flow in vivo and modeling of different conditions in vitro.
Molecular Control and Role of Connexin37
in Lymphatic-Valve Morphogenesis
Connexins play an important role for local and long-range
instructivemorphogenetic cues in development via the establish-
ment of gap-junctional intercellular communication (Wei et al.,
2004). Kanady et al. recently reported failure of lymphatic-valve
formation and lymphatic drainage in Cx37/ and Cx37/;
Cx43+/ mice (Kanady et al., 2011). Here we show that Cx37
controls the precise assembly of a circumferential lymphatic-
valve territory, and we propose that Cx37 mediates cell-cell
communication and collective long-range interactions in this
process (Figure S7). Mechanistically, Cx37 acts downstream of
Prox1, Foxc2, and shear stress, and it is required for a uniform
calcineurin/NFAT activation in response to flow, thus providing
a molecular framework for a stepwise model of lymphatic-valve
morphogenesis. Potentially, Cx37 gap junctions may mediate
transfer of IP3, which triggers the release of intracellular Ca
2+,Developmnecessary for calcineurin/NFAT activation. This concept sup-
ports a putative gap-junction-mediated mechanism for estab-
lishment of a morphogenetic gradient proposed in 2002 (Crab-
tree and Olson, 2002). However, other mechanisms, such as
connexin-mediated release of ATP (Wong et al., 2006) and
increase of intracellular Ca2+ via activated purinergic receptors
should also be considered.
Formation of lymphatic valves is perturbed in mice double
heterozygous for Cx37 and Foxc2, and FOXC2 interacts with
a consensus site identified previously by ChIP-chip analysis
(Norrme´n et al., 2009) and located 44,286 bp upstream of
Cx37 transcription start site (Y. Agalarov, N. Houhou, and M.
Delorenzi, unpublished data). These results further strengthen
the notion that Cx37 is a direct target of FOXC2 and suggest
that decreased Cx37 is one of the reasons for incompetent
valves observed in patients with FOXC2 mutations (Brice et al.,
2002; Mellor et al., 2007).
Calcineurin/NFAT Pathway in Vascular Morphogenesis
In vitro studies postulated that calcineurin/NFAT mediates most
VEGF/VEGFR-2-induced responses of endothelial cells, in-
cluding cell proliferation, migration, and tube formation (Herna´n-
dez et al., 2001; Johnson et al., 2003; Schweighofer et al., 2009;
Zaichuk et al., 2004). Germline inactivation of calcineurin arrests
vascular morphogenesis at the stage of primitive blood capillary
plexus and prevents heart-valve development (Chang et al.,
2004; Graef et al., 2001). Endothelium-specific loss of calcineurin
leads to abnormal coronary-vessel development (Zeini et al.,
2009), but the role of calcineurin in vascular development was
not investigated in either model beyond E12.5. Our results
show that, in contrast to the in vitro results, endothelial calci-
neurin/NFAT is dispensable for Vegf/Vegfr-2-driven angiogen-
esis after midgestation, while signaling in lymphatic vasculature
is important for valve establishment and maintenance. These
data further highlight the complexity and differential require-
ments for the calcineurin pathway during early and late develop-
mental (lymph)angiogenesis.
How does shear stress activate calcineurin in lymphatic valve
cells? In addition to its role in angiogenesis, VEGFR-2 is a
component of the endothelial mechanosensory complex (Tzima
et al., 2005), and it is highly expressed in lymphatic-valve-
forming cells and mature lymphatic valves (Figure 1E and Saar-
isto et al., 2002). Therefore, it is one of the candidate cell surface
sensors for activation of calcineurin/NFAT. Vegfr-2 forms heter-
odimers with Vegfr-3, and its coreceptor neuropilin-2. The latter,
which is important for VEGF-C-induced sprouting of lymphatic
capillaries (Xu et al., 2010), is selectively absent in developing
and mature lymphatic valve cells (Figures 1D and S1D). It will
be important to test in the future to what extent Vegfr-2/Vegfr-3
signal transduction cascades differ in sprouting capillaries
versus lymphatic-valve-forming cells.
Our studies revealed a cell-autonomous requirement for calci-
neurin/NFAT activation in the maintenance of adult lymphatic
valves. Lymphatic valves are the subject of intense shear stress
(Dixon et al., 2006); thus, continuous calcineurin signaling may
be necessary to ensure the survival of valve endothelial cells.
PROX1 and FOXC2 are highly expressed in human and mouse
venous-valve endothelial cells, which also show nuclear NFATc1
localization (Bazigou et al., 2011; our unpublished data), furtherental Cell 22, 430–445, February 14, 2012 ª2012 Elsevier Inc. 441
Figure 7. Analysis of Lymphatic Flow In Vivo
(A) Developing collecting vessels express eNOS before the onset of lymphatic valve formation at E15.5, and eNOS expression is higher in lymphatic-valve-
forming cells and mature valves. Mesenteric vessels were stained for eNOS (red), Prox1 (blue), and Pecam1 (green). A, artery; V, vein; L, lymphatic vessel. Bar,
50 mm in left panel and 20 mm in the other panels.
(B) LVCs have higher levels of podocalyxin. E15.5 and E16.5 mesenteric vessels were stained for podocalyxin (green) and Prox1 (red). Bar, 20 mm.
(C andD) Examples of lymphatic flow in E16.0 or E18.0 embryos, injected with FITC-dextran (gray). Lymphatic flow is reversing in some areas at E16.0, but mostly
directional at E18.0. Four time points for each stage of Movie S1 are shown. The red arrow shows the direction of lymph flow. The arrowheads indicate the end of
the visible dye-filled vessel. Bar, 300 mm.
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These data also suggest that dysfunction of venous and/
or lymphatic circulation may be one of the potential side
effects of a long-term immunosuppressive therapy with cyclo-
sporin A.
In conclusion, our study sheds light on early steps of lymphatic
valve morphogenesis and suggests an important contribution of
mechanical forces to this remodeling process, which act in
concert with the transcription factors Prox1 and Foxc2. We
introduce Cx37 and calcineurin/NFATc1 signaling as mecha-
noresponsive pathways in the lymphatic endothelium and
downstream effectors of Prox1 and Foxc2, where they act
at different stages of lymphatic-valve formation. Our results
show how local increases in the level or activation status of
transcription factors, together with mechanical stimulation, can
be translated into a discrete cell signaling pattern and morpho-
genetic event. They also suggest that endothelial cell identity
controls mechanosensory signal transduction and vascular
remodeling.
EXPERIMENTAL PROCEDURES
Animal Models
Animal experiments were approved by the Animal Ethics Committee of Vaud,
Switzerland, and by the Animal Experimentation Committee of the county
of Mu¨nster, Germany. We used Cnb1f/f, Cx37/, Cdh5(PAC)-CreERT2,
PDGFb-iCreERT2, Prox1-CreERT2, ROSA26R-YFP, and Foxc2/mice (Bazi-
gou et al., 2011; Claxton et al., 2008; Iida et al., 1997; Simon et al., 1997; Wang
et al., 2010; Zeng et al., 2001). Prox1-mOrange2 mice (Hagerling et al., 2011),
tamoxifen treatment, ex vivo culture, antibodies, and staining procedures are
described in the Supplemental Experimental Procedures.
In Vivo Analyses
For microlymphangiography, we injected anesthetized adult mice with 5 ml of
8 mg/ml FITC-dextran (2,000 kDa) or 10mg/ml Evans Blue in PBS.We injected
E16.5 and E18.5 embryos with 0.5 ml of FITC-dextran in the upper hindlimb,
and E14.5 and E15.5 embryos in the buccal region. Embryo viability was
monitored by heart beat and blood flow. Mice were observed under a Leica
M205FA stereomicroscope equipped with DFC300FXR2 camera (Leica) and
the software LAS AF6000, or under a customized two-photon microscope
(TrimScope, LaVision BioTec) and Olympus 203 NA = 0.95 water immersion
objective. Imaging parameters are described in the Supplemental Experi-
mental Procedures. In adult mice lymph vessels were imaged using a dorsal
skinfold chamber (Lehr et al., 1993). All images of whole-mount staining
are shown in the same orientation, i.e., with the direction of flow from bottom
to top.
Cell Culture, Transfection, RNA Isolation, qPCR, and Western Blot
Analyses
Human LECs andmouse endothelial cells, VEGF-C treatment, siRNA transfec-
tion, RNA isolation, reverse transcription, amplification, qPCR, and western
blotting analyses are described in the Supplemental Experimental Procedures.(E) Drainage of FITC-dextran in E15.5 Prox1-mOrange2 embryos. Lymphatic vess
is drained by 10 min postinjection. Bar, 100 mm.
(F) Visualization of lymphatic-valve dynamics in live Prox1-mOrange2 adult mice i
lymphatic vessels (orange) and collagen fibers (green). The double arrow shows
(G) LECs in the valve sinuses subjected to flow recirculation express higher levels
side are subjected to laminar flow and have lower levels of these proteins.
(H) Loss of Prox1 and Foxc2 patterning in collecting lymphatic vessels cultured e
after 2 days of culture. Arrowheads show the forming lymphatic valve, and the a
See also Figure S6 and Movies S1, S2, and S3.
DevelopmRT-qPCR and/or western blot analysis confirmed target mRNA or protein
depletion (Figures S4C, S4F, S4G, S5D, and S5E).
In Vitro Flow Analysis
Confluent LECs on fibronectin-coated slides (m-Slide I0.8 Luer; ibidi) were sub-
jected to laminar (4 dyn/cm2) or oscillatory (4 dyn/cm2, ¼ Hz) flow in a parallel-
plate flow-chamber system (ibidi Pump System, ibidi) or kept under static
conditions for 48 hr. Shear-stress parameters were chosen based on the
measurements reported by Zawieja, (2009). For cell segregation studies,
LECs were transfected with PROX1, FOXC2, VE-cadherin, NRP2, or control
siRNAs. Labeled PROX1high/FOXC2high (20% or 30%, transfection with
AllStars siRNA, labeled with CellTracker Orange CMRA dye, Molecular
Probes, Invitrogen) and unlabeled PROX1low/FOXC2low (80% or 70%,
transfection with PROX1 and FOXC2 siRNAs) cells were mixed, plated at
confluence, and subjected to flow or left under static conditions. Similar
experiments were carried out using mixtures of VE-cadherinhigh/low or
NRP2high/low cells.
Quantification and Statistical Analysis
The number of valves at each developmental stage (Figure 1B) was quantified
using four mesenteric vessels in 3–10 mice/genotype. For Cnb1; Cx37;
Cdh5(PAC)-CreERT2 crosses two double heterozygous embryos from
different litters and eight littermate controls were analyzed. Laminin a5 leaflet
ECM core was measured using ImageJ software on three mesenteric vessels
of neonates or 10 randomly chosen ear valves of adult mice. For flow experi-
ment quantification, the ratio of cell length to width, axis of cell elongation, and
its angle to flow direction defined as in Figure 5Awere calculated using ImageJ
and 100–200 cells per experiment. We quantified nuclear NFATc1 using
ImageJ Mean Gray Value function. Size of cell cluster, defined as a group of
labeled cells in contact with each other, was measured by counting the
number of cells in the cluster.
A two-tailed, unpaired Student’s t test was done to determine statistical
significance by calculating the probability of difference between two means.
The differences were considered statistically significant at p < 0.05. Data are
shown as mean ± SD.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, Supplemental Experimental
Procedures, and three movies and can be found with this article online at
doi:10.1016/j.devcel.2011.12.020.
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